You are here

Home » Buprenorphine for OUD and Chronic Pain

Buprenorphine for OUD and Chronic Pain

This webinar occurred on July, 21, 2022, and expires on July, 22, 2023

Presentation Slides

Please complete this evaluation to receive CME credit.

This webinar will provide a framework for clinicians to address clinical scenarios regarding buprenorphine use. It will address the misconceptions and provide clinical recommendations on the appropriate use of buprenorphine for chronic pain, including conversion strategies for transitioning from a full opioid receptor agonist to buprenorphine. These recommendations should be used by health care providers seeking an alternative to Schedule II opioids.

Topics and Educational Objectives

  1. Review the pharmacology of buprenorphine and use in opioid use disorder (OUD) and pain.

  2. Review the legalities of prescribing buprenorphine for OUD and perceived obstacles.

  3. Empathize with patients taking buprenorphine for OUD.

Target Audience

This activity is designed to educate commission members, practitioners, medical regulatory staff, and the public.

Speaker Biographies

Greg Rudolf, MD, DFASAM

Dr. Rudolf practices pain medicine, addiction medicine, and medical acupuncture at Swedish Pain Services in Seattle.
Trained in family medicine, Dr. Rudolf approaches care of patients with chronic pain and/or SUDs from a holistic perspective, aiming to provide patient-centered, whole-person care. He is the current president of the WA Society of Addiction Medicine, the chair of the American Society of Addiction Medicine Pain and Addiction Committee and serves on the clinical faculty of the UW School of Medicine.


A picture containing personDescription automatically generatedLisa B. Voltarelli, MD (she/her)

Dr. Voltarelli is a current fellow with the Swedish Addiction Medicine program in Seattle, Washington. She received her medical degree from Boston University School of Medicine and completed residency at Swedish First Hill Family Medicine Residency. She is a proponent of integrating addiction care into primary care and all healthcare settings as part of whole-person care. She plans to continue to work caring for vulnerable populations in full spectrum family medicine and addiction medicine. Outside of work she enjoys traveling, exploring new cities and having fun in the outdoors. 



Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Federation of State Medical Boards and the Washington Medical Commission. The Federation of State Medical Boards is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Federation of State Medical Boards designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Director

Alden Roberts, MD
Washington Medical Commission

Commercial Support

This learning activity is not funded by any commercial entity.


As an organization accredited by the ACCME, the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. All faculty, planners, and others in a position to control continuing medical education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Faculty (authors, presenters, speakers) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.

All faculty members are asked to disclose all financial relationships they have had in the past 24 months with ineligible companies regardless of the potential relevance of each relationship to the education and of the amount. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity.

The speakers, course director, authors, and planners have no relevant financial relationships with ineligible companies to disclose.